Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

About Us

BoD

Renee Aguiar-Lucander

  - Director
No Image

Renee Aguiar-Lucander, a director since 2006, is a Partner in the venture capital group of 3i Group Plc, a leading private equity and venture capital firm with about $10bn of assets under management. Mrs Aguiar-Lucander has been a Partner at 3i venture since 2005, where she is responsible for managing the quoted assets and overseeing the European divestment process. In addition, Mrs Aguiar-Lucander is a senior member of the European portfolio management team with a focus on healthcare assets and is on the Board of Idea AG. Prior to joining 3i, Mrs Aguiar-Lucander was a Managing Director in Investment Banking at Lehman Brothers, with a focus on Media, Internet & Communications. Mrs Aguiar-Lucander has over 12 years of corporate finance experience with firms such as BT Alex Brown, Deutsche Bank and Lehman Brothers, where she focused on M&A and private / public capital raising for growth companies in both Europe and the US. Prior to Investment Banking, she worked for 5 years in European sales & marketing for a financial services focused software business. Mrs Aguiar-Lucander has a BA in finance from Stockholm School of Economics and an MBA from Insead.

<< back